Showing results (561-570 of 3,697) with videos related to

Sort By:
Pageof 370
International Journal of Clinical Oncology|December 18, 2023
Current status and future perspective of immunotherapy for renal cell carcinomaLeandro Blas, Keisuke Monji, Jun Mutaguchi, et al.
International Journal of Clinical Oncology|April 2, 2024
Albumin-myosteatosis gauge as a prognostic factor in patients with advanced pancreatic cancer undergoing first-line chemotherapyTaha Koray Sahin, Yakup Ozbay, Ahmet Yasir Altunbulak, et al.
International Journal of Clinical Oncology|February 28, 2024
Peripheral neuropathy and nerve electrophysiological changes with enfortumab vedotin in patients with advanced urothelial carcinoma: a prospective multicenter cohort studyRikiya Taoka, Masaki Kamada, Kazuyoshi Izumi, et al.
International Journal of Clinical Oncology|July 24, 2024
Prognostic significance of inflammatory markers in patients with advanced renal cell carcinoma receiving nivolumab plus ipilimumabTakayuki Nakayama, Hideki Takeshita, Makoto Kagawa, et al.
International Journal of Clinical Oncology|July 17, 2024
Phase 3 THOR Japanese subgroup analysis: erdafitinib in advanced or metastatic urothelial cancer and fibroblast growth factor receptor alterationsNobuaki Matsubara, Yuji Miura, Hiroyuki Nishiyama, et al.
International Journal of Clinical Oncology|July 2, 2024
Pancreatic cancer and sarcopenia: a narrative review of the current statusMariko Tsukagoshi, Kenichiro Araki, Ken Shirabe
International Journal of Clinical Oncology|September 4, 2024
Out-of-pocket fertility preservation expenses: data from a Japanese nationwide multicenter surveyMasanori Ono, Yasushi Takai, Miyuki Harada, et al.
International Journal of Clinical Oncology|August 26, 2024
Lynch syndrome screening in patients with young-onset extra-colorectal Lynch syndrome-associated cancersAtsushi Yamada, Yukari Doi, Sachiko Minamiguchi, et al.
International Journal of Clinical Oncology|September 2, 2024
Clinical outcomes of first-line combination therapy with immune checkpoint inhibitor for metastatic non-clear cell renal cell carcinoma: a multi-institutional retrospective study in JapanAkihiro Yoshimura, Taigo Kato, Yasutomo Nakai, et al.
International Journal of Clinical Oncology|August 27, 2024
A phase 2 study of mobocertinib as first-line treatment in Japanese patients with non-small cell lung cancer harboring EGFR exon 20 insertion mutationsKiyotaka Yoh, Koichi Azuma, Hidetoshi Hayashi, et al.
Pageof 370